AlphaFold predicted structure
JAGN1 · Q8N5M9

Mean pLDDT
91.3/ 100
Very high
183 residues
Confidence breakdown
- Very high(≥ 90)79%
- Confident(70–90)12%
- Low(50–70)9%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
jagunal vesicle mediated transporter 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalautosomal recessive severe congenital neutropenia due to JAGN1 deficiency
severe congenital neutropenia
neurodegenerative disease
hereditary disease
frontotemporal dementia
amyotrophic lateral sclerosis
behavioral variant of frontotemporal dementia
alcohol drinking
pancreatic insulinoma
cyclic hematopoiesis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein jagunal homolog 1
Endoplasmic reticulum transmembrane protein involved in vesicle-mediated transport, which is required for neutrophil function. Required for vesicle-mediated transport; it is however unclear whether it is involved in early secretory pathway or intracellular protein transport. Acts as a regulator of neutrophil function, probably via its role in vesicle-mediated transport: required for defense against fungal pathogens and for granulocyte colony-stimulating factor (GM-CSF) signaling pathway; possibly by regulating glycosylation and/or targeting of proteins contributing to the viability and migration of neutrophils
JAGN1 · Q8N5M9

Mean pLDDT
91.3/ 100
Very high
183 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0